BioAge Labs, Inc.
BIOA
$18.19
$0.030.17%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -89.93M | -80.61M | -75.79M | -79.03M | -71.05M |
| Total Depreciation and Amortization | 239.00K | 213.00K | 191.00K | 180.00K | 171.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.67M | 10.59M | 11.60M | 10.95M | 9.32M |
| Change in Net Operating Assets | -10.29M | -11.83M | 5.49M | 10.49M | 8.34M |
| Cash from Operations | -88.31M | -81.63M | -58.51M | -57.40M | -53.21M |
| Capital Expenditure | -319.00K | -719.00K | -633.00K | -916.00K | -792.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -63.66M | -94.50M | -80.18M | -93.04M | -77.56M |
| Cash from Investing | -63.98M | -95.22M | -80.81M | -93.96M | -78.35M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -6.00M | -6.00M | -6.00M | -6.00M | -6.00M |
| Issuance of Common Stock | 143.89M | 17.87M | 27.65M | 221.83M | 222.25M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.21M | -400.00K | -1.29M | -3.24M | -4.55M |
| Cash from Financing | 136.68M | 11.47M | 20.36M | 212.59M | 211.70M |
| Foreign Exchange rate Adjustments | -102.00K | -87.00K | 69.00K | 21.00K | 50.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.71M | -165.46M | -118.90M | 61.25M | 80.18M |